Medications That Affect C-Reactive Protein (CRP) Levels
Several medications can significantly increase or decrease C-reactive protein (CRP) levels, with statins and corticosteroids having the most pronounced effects on lowering CRP, while certain COX-2 inhibitors may increase CRP levels.
Medications That Lower CRP
Statins
- HMG-CoA reductase inhibitors (statins) have a pronounced CRP-lowering effect that is often independent of their lipid-lowering properties 1, 2
- Atorvastatin demonstrates a dose-dependent reduction in CRP levels 2
- Pravastatin has been shown to significantly decrease CRP levels over a 5-year follow-up period, independent of its effect on lowering LDL cholesterol 3
- The CRP-lowering effect of statins is considered to contribute to their favorable cardiovascular outcomes 2
Corticosteroids
- Prednisone and other glucocorticoids substantially reduce CRP levels (mean reduction of 46% compared to placebo) 4
- This effect is particularly notable in inflammatory conditions, where CRP normalization is often used to guide treatment duration 5
NSAIDs
- Naproxen has been shown to significantly decrease CRP levels in patients with rheumatoid arthritis (standardized mean difference -0.11,95% CI -0.20 to -0.02) 6
- Aspirin reduces serum CRP levels, particularly in patients with elevated inflammatory markers 3, 2
- However, the overall effect of NSAIDs as a class on CRP is variable, with some studies showing no net effect when analyzing multiple NSAIDs together 6
Other Medications
- Angiotensin receptor blockers (ARBs) (particularly valsartan, irbesartan, olmesartan, and telmisartan) markedly reduce CRP levels 2
- ACE inhibitors (ramipril, captopril, fosinopril) reduce CRP, though enalapril and trandolapril have not shown this effect 2
- Antidiabetic agents (rosiglitazone and pioglitazone) reduce CRP levels 2
- Beta-adrenoreceptor antagonists have demonstrated CRP-lowering effects 2
- Platelet aggregation inhibitors (clopidogrel, abciximab) can reduce CRP 2
- Fibrates, niacin, and ezetimibe have shown CRP-lowering properties 2
Medications That Increase CRP
- Lumiracoxib (a COX-2 selective NSAID) causes a statistically significant increase in CRP levels (standardized mean difference 0.13,95% CI 0.01 to 0.25) 6
- Estrogen therapy (oral) does not affect CRP levels according to some studies 2, though other research suggests it may increase CRP
Medications With No Significant Effect on CRP
- Insulin does not significantly affect CRP levels 2
- Hydrochlorothiazide does not affect CRP levels 2
- Procalcitonin (PCT) levels are not affected by glucocorticoids, making PCT potentially more reliable for monitoring infection resolution 4
Clinical Implications
- When monitoring inflammatory conditions, be aware that certain medications may artificially lower CRP values, potentially masking ongoing inflammation
- In patients taking statins or NSAIDs who are being evaluated for inflammatory conditions like giant cell arteritis, CRP may be a superior test compared to ESR, as a study showed these medications lowered ESR but not CRP in this population 7
- For cardiovascular risk assessment, the effect of medications on CRP should be considered when interpreting results
- In inflammatory conditions like pericarditis, CRP normalization is used to guide NSAID treatment duration 5
Common Pitfalls
- Failing to consider medication effects when interpreting CRP levels in clinical decision-making
- Not recognizing that different NSAIDs may have opposing effects on CRP (naproxen lowers while lumiracoxib raises CRP) 6
- Overlooking the fact that glucocorticoids significantly lower CRP but increase leukocyte and neutrophil counts 4
- Assuming all statins have equivalent effects on CRP (the effect appears to be dose-dependent with atorvastatin) 2
Understanding these medication effects on CRP is crucial when using this biomarker for diagnosis, risk assessment, or monitoring treatment response in various clinical scenarios.